生态药物PLUS:用于药物目标保护分析和环境风险评估的先进数据库
Ashenafi Legehar1, Siobhán Monaghan2, Mael Briand1
1Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, Helsinki 00790, Finland.
Nucleic acids research
|November 22, 2025
概括
生态药物PLUS是一个新的数据库,用于评估药品的环境风险. 它有助于调查与野生动物蛋白目标的化学相互作用,有助于风险分析.
科学领域:
- 环境科学 环境科学
- 毒理学 毒理学 毒理学
- 生物信息学是一种生物信息学.
背景情况:
- 药品和其他生物活性物质对环境构成风险.
- 评估这些风险需要了解与野生动物的化学相互作用.
- 现有的数据库可能缺乏全面的数据或用户友好的接口.
研究的目的:
- 引入EcoDrug PLUS,这是一个加强的数据库,用于对生物活性化学品的环境风险评估.
- 提供先进的工具,用于研究野生动物中的化学蛋白目标相互作用.
- 整合各种数据以改善风险分析和测试策略.
主要方法:
- 为EcoDrug+开发了一个增强的图形用户界面.
- 来自开放获取源的综合基因组和化学信息数据.
- 实现了高级搜索功能,包括文本查询,结构图和BLAST.
- 将化学数据组织成集群,并提供交互式知识图.
- 结合了基于效应的知识和地理参考的环境度数据.
主要成果:
- EcoDrug+提供了一个广泛而直观的环境风险评估平台.
- 该数据库涵盖药品,农业化学品,代谢物和其他生物活性化学品.
- 先进的搜索和数据组织有助于探索化学相互作用和相似之处.
- 综合数据支持对测试终点和敏感物种的知情决策.
- 为风险分析提供暴露数据.
结论:
- 生态药物PLUS显著提高了生物活性化学品的环境风险评估能力.
- 该数据库是研究人员和监管机构的宝贵,免费可访问的资源.
- 其全面的数据整合和先进的工具提高了对野生动物化学影响的理解.
更多相关视频
05:47In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
14.5K
07:40A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
4.5K
相关概念视频
01:26Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
01:26Targets for Drug Action: Overview
9.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.9K
01:19Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
01:28Structure-Activity Relationships and Drug Design
1.6K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
154
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
154
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
132
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
132